Tetracosactide acetate

CAS No. 60189-34-6

Tetracosactide acetate( Tetracosactrin acetate )

Catalog No. M28050 CAS No. 60189-34-6

Cosyntropin (acetate) stimulates the release of corticosteroids such as cortisol from the adrenal gland.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 112 In Stock
10MG 183 In Stock
25MG 312 In Stock
50MG 440 In Stock
100MG 603 In Stock
200MG 812 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tetracosactide acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    Cosyntropin (acetate) stimulates the release of corticosteroids such as cortisol from the adrenal gland.
  • Description
    Cosyntropin (acetate) stimulates the release of corticosteroids such as cortisol from the adrenal gland.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tetracosactrin acetate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    60189-34-6
  • Formula Weight
    2993.5
  • Molecular Formula
    C136H210N40O31S.XC2H4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N/A
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang M, et al. Improving the flame retardancy of poly(lactic acid) using an efficient ternary hybrid flame retardant by dual modification of graphene oxide with phenylphosphinic acid and nano MOFs. J Hazard Mater. 2020 Feb 15;384:121260.
molnova catalog
related products
  • Baohuoside VII

    Baohuoside VII is a flavonoid isolated from Herba Epimedii, with anti-osteoporosis activities.

  • Frangulin A

    Frangulin A protects Vitis vinifera leaves from Plasmopara viticola infection and inhibits the first stage of biotrophic hyphal development of P. Viticola.

  • Icotinib Hydrochlori...

    Icotinib Hydrochloride is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity.